JP2008500363A5 - - Google Patents

Download PDF

Info

Publication number
JP2008500363A5
JP2008500363A5 JP2007515318A JP2007515318A JP2008500363A5 JP 2008500363 A5 JP2008500363 A5 JP 2008500363A5 JP 2007515318 A JP2007515318 A JP 2007515318A JP 2007515318 A JP2007515318 A JP 2007515318A JP 2008500363 A5 JP2008500363 A5 JP 2008500363A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
alkyl
alkylaryl
arylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007515318A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008500363A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/018443 external-priority patent/WO2005117590A2/en
Publication of JP2008500363A publication Critical patent/JP2008500363A/ja
Publication of JP2008500363A5 publication Critical patent/JP2008500363A5/ja
Pending legal-status Critical Current

Links

JP2007515318A 2004-05-26 2005-05-25 新規化合物、該化合物を含む医薬組成物、および該化合物の使用方法 Pending JP2008500363A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57463904P 2004-05-26 2004-05-26
PCT/US2005/018443 WO2005117590A2 (en) 2004-05-26 2005-05-25 Novel compounds, pharmaceutical compositions containing same, and methods of use for same

Publications (2)

Publication Number Publication Date
JP2008500363A JP2008500363A (ja) 2008-01-10
JP2008500363A5 true JP2008500363A5 (cg-RX-API-DMAC7.html) 2008-07-17

Family

ID=35463277

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007515318A Pending JP2008500363A (ja) 2004-05-26 2005-05-25 新規化合物、該化合物を含む医薬組成物、および該化合物の使用方法

Country Status (13)

Country Link
US (1) US20090005435A1 (cg-RX-API-DMAC7.html)
EP (1) EP1758577A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008500363A (cg-RX-API-DMAC7.html)
KR (1) KR20070095754A (cg-RX-API-DMAC7.html)
CN (1) CN101022792A (cg-RX-API-DMAC7.html)
AU (1) AU2005249437A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0510397A (cg-RX-API-DMAC7.html)
CA (1) CA2568639A1 (cg-RX-API-DMAC7.html)
IL (1) IL179530A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06013687A (cg-RX-API-DMAC7.html)
RU (1) RU2006146051A (cg-RX-API-DMAC7.html)
WO (1) WO2005117590A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200700024B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007014248A2 (en) * 2005-07-26 2007-02-01 Johns Hopkins University Method of reducing food intake
AU2007300627B2 (en) * 2006-09-22 2012-02-16 Merck Sharp & Dohme Corp. Method of treatment using fatty acid synthesis inhibitors
KR101640263B1 (ko) * 2007-10-05 2016-07-15 젠자임 코포레이션 세라마이드 유도체로 다낭성 신장질환을 치료하는 방법
WO2010118324A2 (en) 2009-04-09 2010-10-14 Nuclea Biotechnologies, LLC Antibodies against fatty acid synthase
WO2014039769A1 (en) * 2012-09-07 2014-03-13 Janssen Pharmaceutica Nv Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
CA2968288A1 (en) 2014-11-20 2016-05-26 Vib Vzw Means and methods for treatment of early-onset parkinson's disease
CN114980740A (zh) 2020-01-23 2022-08-30 巴斯夫欧洲公司 用于农业化学配制剂的新型添加剂
CN116507203B (zh) 2020-10-27 2026-08-07 巴斯夫欧洲公司 农药微乳剂组合物
CA3207197A1 (en) 2021-02-05 2022-08-11 Murat Mertoglu Liquid herbicidal compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3427847A1 (de) * 1983-12-09 1985-06-13 Bayer Ag, 5090 Leverkusen Thiolan-2,4-dion-3-carboxamide
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
US5981575A (en) * 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass
MXPA04007556A (es) * 2002-02-08 2005-12-05 Univ Johns Hopkins Med Estimulacion de cpt-1 como medio para reducir peso.
US7649012B2 (en) * 2002-07-09 2010-01-19 Fasgen, Inc. Compounds, pharmaceutical compositions containing same, and methods of use for same

Similar Documents

Publication Publication Date Title
JP2005533835A5 (cg-RX-API-DMAC7.html)
JP2006505543A5 (cg-RX-API-DMAC7.html)
JP2008511601A5 (cg-RX-API-DMAC7.html)
JP2023523130A5 (cg-RX-API-DMAC7.html)
RU2397976C2 (ru) Производные бензамидов и гетероаренов
JP2010515731A5 (cg-RX-API-DMAC7.html)
JP2008505157A5 (cg-RX-API-DMAC7.html)
JP2007511546A5 (cg-RX-API-DMAC7.html)
JP2008510770A5 (cg-RX-API-DMAC7.html)
JP2009525302A5 (cg-RX-API-DMAC7.html)
JP2003513015A5 (cg-RX-API-DMAC7.html)
JP2009511508A5 (cg-RX-API-DMAC7.html)
JP2006524660A5 (cg-RX-API-DMAC7.html)
JP2010504908A5 (cg-RX-API-DMAC7.html)
JP2008508360A5 (cg-RX-API-DMAC7.html)
JP2022547888A5 (cg-RX-API-DMAC7.html)
JP2010519270A5 (cg-RX-API-DMAC7.html)
EP2412707A3 (en) 3-[2-(3-Amino-2-oxo-2H-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
JP2002527414A5 (cg-RX-API-DMAC7.html)
JP2012530758A5 (cg-RX-API-DMAC7.html)
JP2007526331A5 (cg-RX-API-DMAC7.html)
JP2007502817A5 (cg-RX-API-DMAC7.html)
JP2007515467A5 (cg-RX-API-DMAC7.html)
JP2013503881A5 (cg-RX-API-DMAC7.html)
JP2012511558A5 (cg-RX-API-DMAC7.html)